IGMS
IGM Biosciences Inc

1,316
Loading...
Loading...
News
all
press releases
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates
IGM Biosciences (IGMS) delivered earnings and revenue surprises of +626.67% and +4,388.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
Zacks·4mo ago
News Placeholder
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates
Zacks·4mo ago
News Placeholder
Monte Rosa Therapeutics (GLUE) Tops Q1 Earnings and Revenue Estimates
chainwire·4mo ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of...
PR Newswire·8mo ago
News Placeholder
Futures Fall As Jittery Traders Take Cover Ahead Of Payrolls
Futures Fall As Jittery Traders Take Cover Ahead Of Payrolls US equity futures are lower as traders took a cautious stance ahead of US jobs data that will offer fresh insight on the...
Zero Hedge·8mo ago
News Placeholder
Snowflake Stock Jumps Over 21% In Premarket Following Beat-and-Raise Q3: Retail Braces For ‘Parabolic’ Run
Snowflake CEO Sridhar Ramaswamy said, “Our obsessive drive to produce product cohesion and ease of use has built Snowflake into the easiest and most cost effective enterprise data platform.”
Stocktwits·10mo ago
News Placeholder
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
IGM Biosciences shifts focus to autoimmune diseases, reduces oncology research, and appoints former Bristol Myers Squibb executive as CEO. The company aims to extend its cash runway into 2027. read...
Benzinga·1y ago
News Placeholder
The Analyst Verdict: IGM Biosciences In The Eyes Of 5 Experts
Latest Ratings for IGMS DateFirmActionFromTo Dec 2021HC Wainwright & Co.MaintainsBuy Dec 2021Morgan StanleyDowngradesOverweightEqual-Weight Dec 2021StifelMaintainsBuy View More Analyst Ratings...
Benzinga·1y ago
News Placeholder
IGM Biosciences Refocuses Genzyme Collaboration on Immunology
IGM Biosciences (IGMS) has shared an update. IGM Biosciences, Inc. has shifted its collaboration with Genzyme Corporation to focus solely on immuno...
TipRanks Financial Blog·1y ago

Latest IGMS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.